Emergence of AI Healthcare Policy Amidst Fragme...

By João L. Carapinha

May 25, 2026

The rapid evolution of AI Healthcare Policy is evident in the Health & AI Policy Index (HAPI) snapshot from January 1, 2026, which catalogs 240 policies illustrating swift expans...
Hepcludex HDV Approval: A Breakthrough in Chronic Hepatitis Delta Treatment
CHMP Recommendations 2026: New Approvals and Implications for Health Economics
Clinical Trial Monitoring: Insights from Q1 2026 EU/EEA Report
Novartis Oncology Advancements: Key Trial Findings and Market Implications
EUDAMED Implementation 2026: Key Changes and National Adaptations
Baxfendy Hypertension Treatment: FDA Approves First-in-Class Aldosterone Synt...
TrumpRx.gov Expansion: Enhancing Medication Price Transparency and Competition
Trastuzumab-Deruxtecan Reimbursement: A Careful Evaluation of Cost-Effectiven...
Portugal Health Spending 2025 Reaches Record €4.417 Billion Amid Rising Demand
Substandard Medicines in South Africa: Regulatory Challenges and Economic Imp...
First-in-Human Trials: Foundations and Market Implications in Health Economics
Transforming Healthcare Value: Strategic Purchasing in South Africa